ARTICLE | Clinical News
INO-4913 regulatory update
September 1, 2003 7:00 AM UTC
The FDA granted Orphan Drug designation for INO-4913 to treat cystic fibrosis (CF). The compound, which regulates the sodium and chloride ions that control airway surface liquid volume, is expected to...